Zoledronic acid causes enhancement of bone growth into porous implants

Journal of Bone and Joint Surgery - Series B

Volumn 87, Issue 3, 2005, Pages 416-420

  Bobyn, J D ^a,b   Hacking, S A ^a   Krygier, J J ^b   Harvey, E J ^a   Little, D G ^c   Tanzer, M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; SODIUM CHLORIDE; TANTALUM; ZOLEDRONIC ACID; IMIDAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEMINERALIZATION; BONE GRAFT; BONE GROWTH; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOG; DOSE RESPONSE; EXPERIMENTAL MODEL; FRACTURE FIXATION; HISTOPATHOLOGY; NONHUMAN; OSSIFICATION; POROSITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TISSUE SECTION; ULNA; ANIMAL; BONE REGENERATION; BONE TRANSPLANTATION; DRUG EFFECT; METHODOLOGY; PHYSIOLOGY; PROSTHESES AND ORTHOSES;

ANIMALS; BONE TRANSPLANTATION; DIPHOSPHONATES; DOGS; IMIDAZOLES; MICROSCOPY, ELECTRON, SCANNING; OSSEOINTEGRATION; PROSTHESES AND IMPLANTS; TANTALUM; ULNA;

EID: 15044354483     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.87B3.14665     Document Type: Article

References (41)

1. Engh CA, Claus AM, Hopper RH, Engh CA. Long-term results using the anatomic medullary locking hip prosthesis. Clin Orthop 2001;393:137-46.
2. Teloken MA, Bissett G, Hozack WJ, Sharkey PF, Rothman RH. Ten to fifteen-year follow-up after total hip arthroplasty with a tapered cobalt-chromium femoral component (tri-lock) inserted without cement. J Bone Joint Surg [Am] 2002;84-A: 2140-4.
3. D'Antonio JA, Capello WN, Manley MT, Geesink R. Hydroxyapatite femoral stems for total hip arthroplasty: 10- to 13-year followup. Clin Orthop 2001;393:101-11.
4. Pidhorz LE, Urban RM, Jacobs JJ, Sumner DR, Galante JO. A quantitative study of bone and soft tissues in cementless porous-coated acetabular components retrieved at autopsy. J Arthroplasty 1993;8:213-25.
5. Sychterz CJ, Claus AM, Engh CA. What we have learned about long-term cementless fixation from autopsy retrievals. Clin Orthop 2002;405:79-91.
6. Bobyn JD, Jacobs JJ, Tanzer et al. The susceptibility of smooth implant surfaces to peri-implant fibrosis and migration of polyethylene wear debris. Clin Orthop 1995; 311:21-39.
7. Kienapfel H, Sumner DR, Turner TM, Urban RM, Galante JO. Efficacy of autograft and freeze-dried allograft to enhance fixation of porous coated implants in the presence of interface gaps. J Orthop Res 1992;10:423-33.
8. McDonald DJ, Fitzgerald RH Jr, Chao EYS. The enchancement of fixation of a porous-coated femoral component by autograft and allograft in the dog. J Bone Joint Surg [Am] 1988;70-A:728-37.
9. McLaughlin RE, Reger SI, Bolander M, Eschenroeder HC. Enhancement of bone ingrowth by the use of bone matrix as a biologic cement. Clin Orthop 1984;183:255-61.
10. Cook SD, Salkeld SL, Patron LP, Barrack RL. The effect of demineralized bone matrix gel on bone ingrowth and fixation of porous implants. J Arthroplasty 2002; 17: 402-8.
11. Kienapfel H, Sumner DR, Turner TM, et al. Efficacy of autograft, freeze dried allograft and fibrin glue to enhance fixation of porous-coated implants in the presence of interface gaps [abstract]. Trans Orthop Res Soc 1990;15:432.
12. Russotti GM, Okada Y, Fitzgerald RH Jr, Chao EYS, Gorski JP. Efficacy of using a bone graft substitute to enhance biological fixation of a porous metal femoral component. In: Brand RA, ed. The Hip. Proc of 15th open science meeting of Hip Society, St Louis: Mosby, 1987:120-54.
13. Longo JA, Weinstein AM, Hadley AK. The effects of collagen on tissue growth into a porous polyethylene ingrowth model. In: Christel P, Meunier A, Lee AJC, eds. Biological and biomechanical performances of biomaterials. Amsterdam: Elsevier Science Publishers B.V., 1986:483-8.
14. Alberts LR. Effects of periosteal activation agent on bone repair and ingrowth. J Biomed Mater Res 1987;21:429-42.
15. Berry JL, Geiger JM, Moran JM, Skraba JS, Greenwald AS. Use of tricalcium phosphate or electrical stimulation to enhance the bone-porous implant interface. J Biomed Mater Res 1986;20:65-77.
16. Cook SD, Thomas KA, Kay JF, Jarcho M. Hydroxyapatite-coated porous titanium for use as an orthopedic biologic attachment system. Clin Orthop 1988;230:303-12.
17. Rivero DP, Fox J, Skipor AK, Urban RM, Galante JO. Calcium-phosphate-coated titanium implants for enhanced skeletal fixation. J Biomed Mater Res 1988;22:191-201.
18. 2 alpha on bone ingrowth into a porous-coated implant [abstract]. Trans Orthop Res Soc 1990;15:167.
19. Sumner DR, Turner TM, Purchio AF, et al. Enhancement of bone ingrowth by transforming growth factor beta. J Bone Joint Surg [Am] 1995;77-A:1135-47.
20. Sumner DR, TurnerTM, Urban RM, et al. Locally delivered rh TGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury. J Orthop Res 2001:19:85-94.
21. Rivero DP, Landon GC, Skipor AK, Urban RM, Galante JO. Effect of pulsing electromagnetic fields on bone ingrowth in a porous material [abstract]. Trans Orthop Res Soc 1986;11:492.
22. Tanzer M, Kantor S, Bobyn JD. Enhancement of bone growth into porous intramedullary implants using non-invasive low intensity ultrasound. J Orthop Res 2001;19: 195-9.
23. Tanzer M, Harvey E, Kay A, Morton P, Bobyn JD. Effect of noninvasive low intensity ultrasound on bone growth into porous-coated implants. J Orthop Res 1996;14: 901-6.
24. Bragdon CR, Doherty AM, Rubash HE, et al. Efficacy of MBP-2 to induce bone ingrowth in gap and non-gap regions of a THR model. Clin Orthop 2003;417:50-61.
25. Barrack RL, Cook SD, Patron LR et al. Induction of bone ingrowth from an acetabular defect to a porous surface with osteogenic protein-1. Clin Orthop 2003;417:41-9.
26. Sumner DR, Turner TM, Urban RM, et al. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res 2004;22:58-65.
27. Cole BJ, Bostrom MPG, Pritchard TL, et al. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clin Orthop 1997;345:219-28.
28. Green JR, Müller K, Jaeggi KA. Preclinical pharmacology of CGP42′446, a new, potent, heterocyclic bisphosphonate compound. J Bone Miner Res 1994;9:745-51.
29. Pataki A, Müller K, Green JR, et al. Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anat Rec 1997;249:458-68.
30. Shanbhag AS, Hasselman CT, Rubash HE. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop 1997;344:33-43.
31. Shanbhag AS, May D, Cha C, Kovach C, Hasselman CT, Rubash HE. Enhancing net bone formation in canine total hip components with bisphosphonates [abstract]. Trans Orthop Res Soc 1999;24:255.
32. Soininvaara TA, Jurvelin JS, Miettinen HJA, et al. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients. Calcif Tissue Int 2002;71:472-7.
33. Venesmaa PK, Kroger JP, Miettinen HJ, et al. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study. J Bone Miner Res 2001;16:2126-31.
34. Wilkinson JM, Stockley I, Peel NF, et al. Effect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial. J Bone Miner Res 2001;16:556-64.
35. Little DG, Cornell MS, Briody J, et al. Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis: a study in immature rabbits. J Bone Joint Surg [Br] 2001;83-B:1069-74.
36. Little DG, Smith NC, Williams F, et al. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Mlner Res 2003;18:1300-7.
37. Bobyn JD, Stackpool GJ, Hacking SA, Tenzer M, Krygier JJ. Bone ingrowth characteristics and interface mechanics of a new porous tantalum biomaterial. J Bone Joint Surg [Br] 1999;81-B:907-14.
38. Bobyn JD, Tok K-K, Hacking SA, Tanzer M, Krygier JJ. The tissue response to porous tantalum acetabular cups: a canine model. J Arthroplasty 1999;14:347-54.
39. Day J, Ding M, Bednarz P, et al. Bisphosphonates affect the apparent modulus of trabecular bone through architecture and not mineralization [abstract]. Trans Orthop Res Soc 2002,27:85.
40. Smith EJ, Bugler J, Peat RA, et al. Zoledronic acid modulates bone repair through transiently delayed remodelling [abstract]. Trans Orthop Res Soc 2003;28:351.
41. Howie DW, McGee MA, Findlay DM, et al. Use of OP-1 in femoral impaction grafting in a sheep hemiarthroplasty model [abstract]. Trans Orthop Res Soc 2003;28: 32.